Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?

S Rijal, V Yardley, F Chappuis, S Decuypere, B Khanal, R Singh, M Boelaert, S De Doncker, S Croft, JC Dujardin

    Research output: Contribution to journalA1: Web of Science-article

    Original languageEnglish
    JournalMicrobes and Infection
    Issue number4
    Pages (from-to)529-535
    Publication statusPublished - 2007


    • B780-tropical-medicine
    • Protozoal diseases
    • Leishmaniasis
    • Visceral
    • Kala azar
    • Leishmania donovani
    • Drug therapy
    • Antimonials
    • Sodium stibogluconate
    • Efficacy
    • Treatment outcome
    • Drug sensitivity testing
    • Evaluation
    • Nepal
    • Asia-South

    Cite this